These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30928532)

  • 41. Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study.
    Schnabel P; Merki-Feld GS; Malvy A; Duijkers I; Mommers E; van den Heuvel MW
    Clin Drug Investig; 2012 Jun; 32(6):413-22. PubMed ID: 22540269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bleeding profile in users of an etonogestrel sub-dermal implant: effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population.
    Di Carlo C; Guida M; De Rosa N; Sansone A; Gargano V; Cagnacci A; Nappi C
    Gynecol Endocrinol; 2015 Jun; 31(6):491-4. PubMed ID: 26213863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acceptability of ENG-releasing subdermal implants among postpartum Brazilian young women during the COVID-19 pandemic.
    Barbieri MM; Herculano TB; Dantas Silva A; Bahamondes L; Juliato CRT; Surita FG
    Int J Gynaecol Obstet; 2021 Jul; 154(1):106-112. PubMed ID: 33656758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial.
    Hou MY; McNicholas C; Creinin MD
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial.
    Lombardi Fäh V; Catarino R; Castillo S; Badda M; Gezer-Dickschat S; Thieringer F; Tschudin S; Viviano M; Yaron M
    BMC Res Notes; 2023 Mar; 16(1):35. PubMed ID: 36915205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progestin-only contraceptives: effects on weight.
    Lopez LM; Ramesh S; Chen M; Edelman A; Otterness C; Trussell J; Helmerhorst FM
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008815. PubMed ID: 27567593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amenorrhea in adolescents using the etonogestrel contraceptive implant.
    Tsevat D; Mercier R; Bernheimer C; Lin S; Schwartz B
    Contraception; 2024 May; 133():110413. PubMed ID: 38401772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bleeding related to etonogestrel subdermal implant in a US population.
    Casey PM; Long ME; Marnach ML; Bury JE
    Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immediate postpartum initiation of etonogestrel-releasing implant: A randomized controlled trial on breastfeeding impact.
    Braga GC; Ferriolli E; Quintana SM; Ferriani RA; Pfrimer K; Vieira CS
    Contraception; 2015 Dec; 92(6):536-42. PubMed ID: 26209863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Weight change in adolescents who used hormonal contraception.
    Risser WL; Gefter LR; Barratt MS; Risser JM
    J Adolesc Health; 1999 Jun; 24(6):433-6. PubMed ID: 10401972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.
    Moray KV; Chaurasia H; Sachin O; Joshi B
    Reprod Health; 2021 Jan; 18(1):4. PubMed ID: 33407632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
    Moeti DMP; Govender I; Bongongo T
    S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Aquilante CL; Sheeder J; Guiahi M; Teal S
    Contraception; 2019 Jul; 100(1):37-41. PubMed ID: 30980827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception.
    Lazorwitz A; Aquilante CL; Shortt JA; Sheeder J; Teal S; Gignoux CR
    Clin Transl Sci; 2021 Sep; 14(5):1713-1718. PubMed ID: 33650294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The safety of intrauterine devices among young women: a systematic review.
    Jatlaoui TC; Riley HEM; Curtis KM
    Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Weight Gain Patterns in Adolescent and Young Adult Women With the Etonogestrel Implant: Comparison by Weight Category.
    Batt CE; Sheeder J; Love-Osborne K
    J Adolesc Health; 2021 Nov; 69(5):815-823. PubMed ID: 34154904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective pilot study to assess the impact of the etonogestrel implant on postpartum depression.
    Ross CM; Hammond C; Ralph JA; Balmert LC; Wisner KL; Kiley JW
    Eur J Contracept Reprod Health Care; 2021 Apr; 26(2):98-104. PubMed ID: 33164593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study.
    Short M; Dallay D; Omokanye S; Stauch K; Inki P
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):29-38. PubMed ID: 24289528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study.
    Hernandez-Juarez J; Garcia-Latorre EA; Moreno-Hernandez M; Moran-Perez JF; Rodriguez-Escobedo MA; Cogque-Hernandez G; Julián-Nacer R; Hernandez-Giron X; Palafox-Gomez R; Isordia-Salas I; Majluf-Cruz A
    Reprod Health; 2014 Apr; 11():33. PubMed ID: 24767248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subdermal Contraceptive Implant Insertion Trends and Retention in Adolescents.
    Tyson N; Lopez M; Merchant M; Postlethwaite D
    J Pediatr Adolesc Gynecol; 2021 Jun; 34(3):348-354. PubMed ID: 33388444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.